EAPHARMA
LIVE

Serial Number

98365237

Owner

EA Pharma Co., Ltd.

Attorney

Matthew L. Frisbee

Filing Date

Jan 19, 2024

Add to watchlist:

No watchlists yet
View on USPTO

EAPHARMA Trademark

Serial Number: 98365237

EAPHARMA is a trademark filed by EA Pharma Co., Ltd. on January 19, 2024. The trademark is classified under Class 5 (Pharmaceuticals), Class 42 (Computer & Scientific), Class 44 (Medical Services). The application is currently pending registration.

Owner Contact Info

EA Pharma Co., Ltd. (4 trademarks)

2-1-1, Irifune, Chuo-ku
Tokyo 104-0042 , JP

Entity Type: 03

Trademark Details

Filing Date

January 19, 2024

Registration Date

Not Registered

Goods & Services

Pharmaceutical research and development, namely, pharmaceutical testing, inspection and research

Pharmaceutical preparations for the treatment of autoimmune, cardiovascular, central nervous system, endocrine, gastrointestinal, genetic, immunological, inflammatory, namely except inflammatory bronchial disease, metabolic, neurodegenerative, neurological, psychiatric, oncological, and viral diseases and disorders; Pharmaceutical preparations for the treatment of liver diseases and disorders, erectile dysfunction, sexual dysfunction, cancer, pain, and diabetes; Reagent paper for medical purposes

Medical information; Providing health care information via a global computer network

Filing History

REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED
Dec 9, 2025 RCSC
TEAS CHANGE OF CORRESPONDENCE RECEIVED
Jun 17, 2025 TCCA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Jun 17, 2025 ARAA
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Jun 17, 2025 REAP
REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED
Jun 2, 2025 RCSC
NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
Nov 19, 2024 GNS3
LETTER OF SUSPENSION E-MAILED
Nov 19, 2024 GNSL
SUSPENSION LETTER WRITTEN
Nov 19, 2024 CNSL
TEAS/EMAIL CORRESPONDENCE ENTERED
Oct 25, 2024 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Oct 25, 2024 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Oct 25, 2024 TROA
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Aug 14, 2024 GNRN
NON-FINAL ACTION E-MAILED
Aug 14, 2024 GNRT
NON-FINAL ACTION WRITTEN
Aug 14, 2024 CNRT
ASSIGNED TO EXAMINER
Aug 14, 2024 DOCK
NOTICE OF DESIGN SEARCH CODE E-MAILED
Jun 15, 2024 MDSC
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Jun 15, 2024 NWOS
NEW APPLICATION ENTERED
Jan 19, 2024 NWAP